VC

This section provides exclusive insights from Venture Capital (VC) firms, including investment trends, funding rounds, and emerging opportunities in the startup ecosystem. Understanding the VC landscape is crucial for founders looking to raise capital, navigate funding stages, and build relationships with investors.

Stay updated on the latest funding rounds, market shifts, and VC-backed success stories. Learn about investment strategies, due diligence, and what top venture firms look for in startups. This section also features interviews with investors and deep dives into funding trends across industries like AI, fintech, and healthcare.

This section is curated by:

Sofya Zhamoitina

Venture Reporter

Venture Reporter at The Top Voices | Startup ecosystem navigator | Tracking early-stage funding, sharing tech insights, and publicly supporting founders | Business Administration and International Finance student at Bahcesehir University

AI VC

February 14, 2025

2 min

Akamas Secures $10M to Expand AI-Driven Cloud Optimization in North America

Akamas secured $10M from United Ventures to expand in North America, boost product development, and optimize cloud and Kubernetes.

February 14, 2025

2 min

StemSight Secures €2.3M to Advance Stem Cell Therapy for Corneal Blindness

StemSight raised €2.3M for stem cell therapies targeting vision restoration and limbal stem cell deficiency.

February 13, 2025

1 min

Bluebook Secures $3M to Revolutionize AI-Powered Accounting

Bluebook's AI agents help accounting firms scale from 20 to 200 clients by automating research, reconciliations, and closings.

February 12, 2025

2 min

Mundi Secures $2.5M to Enhance Capital Markets Access for SMEs

Mundi raised $2.5 million in a funding round led by Speedinvest and DeBa Ventures to expand financial inclusivity for SMEs in Türkiye.

VC Health

February 12, 2025

2 min

Votum.World Raises €432,000 Through Startupxplore to Boost Biotech Growth

Votum.World has raised €432K via Startupxplore, aiming for €550K to boost its growth and attract strategic investors in the competitive biotech sector.

Previous Next

This section is curated by:

Sofya Zhamoitina

Venture Reporter